Molecular Partners AG
NASDAQ:MOLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Molecular Partners AG
NASDAQ:MOLN
|
CH |
|
K
|
Krungthai Card PCL
SET:KTC
|
TH |
|
P
|
Precious Shipping PCL
SET:PSL
|
TH |
|
General de Alquiler de Maquinaria SA
MAD:GAM
|
ES |
|
Indofood Agri Resources Ltd
SGX:5JS
|
SG |
|
Tianjin Hi-Tech Development Co Ltd
SSE:600082
|
CN |
|
Video Display Corp
OTC:VIDE
|
US |
|
Bank Danamon Indonesia Tbk PT
IDX:BDMN
|
ID |
|
Philly Shipyard ASA
OSE:PHLY
|
NO |
|
OZ Minerals Ltd
ASX:OZL
|
AU |
|
SERIO Holdings Co Ltd
TSE:6567
|
JP |
|
D
|
Dongwha Enterprise Co Ltd
KOSDAQ:025900
|
KR |
|
MyState Ltd
ASX:MYS
|
AU |
Bankruptcy Probability
Molecular Partners AG's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Molecular Partners AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
Molecular Partners AG
SIX:MOLN
|
125.9m CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
35.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Molecular Partners AG's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Molecular Partners AG has total debt of 2.4m CHF. This includes both short-term (0 CHF) and long-term (2.4m CHF) debt.
You can find a full breakdown on its Balance Sheet.
